Clarivate Divests Life Sciences & Healthcare Segment to Altaris for $600 Million
July 6, 2026
Clarivate entered into a definitive agreement to divest its Life Sciences & Healthcare (LS&H) segment to Altaris LLC for $600 million. The deal is structured with $500 million cash at closing, $25 million in cash deferred for a transition services agreement, and a $75 million seller note, with proceeds intended to reduce Clarivate’s debt.
- Buyers
- Altaris LLC
- Targets
- Clarivate Life Sciences & Healthcare segment
- Sellers
- Clarivate Plc
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.